Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA
Why the study?
Does extended battery longevity of ICDs and CRT-D devices improve clinical outcomes and reduce long-term costs?
Population
Patients requiring implantable cardioverter-defibrillators or cardiac resynchronization therapy defibrillators
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Extended ICD longevity may reduce replacements, infections, and costs; leaves open need for prospective outcome confirmation.
Structured PICO
Does extended battery longevity of ICDs and CRT-D devices improve clinical outcomes and reduce long-term costs?
P
Population
Patients requiring implantable cardioverter-defibrillators (ICDs) or cardiac resynchronization therapy defibrillators (CRT-D)
I
Intervention
ICDs and CRT-D devices with extended battery longevity
O
Outcome
Clinical benefits (reduced need for device replacements and associated complications, particularly infections) and economic benefits (reduced long-term costs)
Extended battery longevity in ICDs and CRT-Ds offers significant clinical benefits by reducing replacement-related complications and provides substantial long-term economic savings.
Cite This Study
Boriani et al. (2018) studied this question.